Qiuzhong Pan
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
CPNE1 promotes stemness and confers resistance to GPC3 CAR-T cell therapy in hepatocellular carcinoma via the STAT3-TGF-β signaling pathway.
Journal: Journal for immunotherapy of cancer
Published: July 21, 2026
Long-term results of multi-antigen stimulated cell therapy-I, alone or in combination with chemotherapy, as first-line maintenance therapy in advanced sarcoma: a multicenter, phase 1 trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 08, 2026
Anlotinib plus toripalimab in patients with advanced bone and soft tissue sarcomas including ultra-rare sarcomas: A multicenter, single-arm, phase 2 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 30, 2026
Blockade of the CLCF1-CNTFR axis enhances the efficacy of GPC3 CAR-T cell therapy in hepatocellular carcinoma.
Journal: Pharmacological research
Published: February 26, 2026
HNRNPD Induces Radioresistance in Nasopharyngeal Carcinoma by Sequestering GRAMD4 mRNA in Stress Granules.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 23, 2025
Annexin A3 potentiates lenvatinib resistance in hepatocellular carcinoma through multiple approaches amplified by a positive feedback loop.
Journal: Cell death & disease
Published: September 11, 2025
The CXCL10-CXCR3 Axis Induces Tumor-Associated Neutrophils to Interfere with CTLs-Mediated Antitumor Activity in EBV-Associated Epithelial Cancers.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 20, 2025
EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment.
Journal: Theranostics
Published: June 27, 2024
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion.
Journal: Journal for immunotherapy of cancer
Published: May 21, 2024
FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcoma.
Journal: Cancer gene therapy
Published: November 11, 2023
Last Updated: 09/26/2026